The Green Bamboo Biotechnology Zhuhai project undertaken by BRSE has reached an important milestone in its construction; — The project has been successfully completed and officially entered the production phase. This achievement marks a significant breakthrough in cooperation between the two sides and injects new momentum into the development of the biopharmaceutical industry. ​

The Green Bamboo Biotechnology Zhuhai project has a grand scale, covering advanced biopharmaceutical production workshops, research and development centers, and supporting facilities, committed to building a modern industrial base integrating vaccine research and development, production, and sales. The project adopts high standards and strict requirements from planning and design to construction, ensuring that every link complies with international biopharmaceutical production standards. ​

During the construction process, BRSE fully utilized its professional advantages, formed an elite team, overcame difficulties such as tight construction schedules and complex technology, scientifically allocated resources, strictly controlled quality and safety, and ensured the smooth progress of the project with efficient and high-quality construction services. After the project is put into operation, it is expected to significantly increase the production capacity of Green Bamboo Biotechnology, accelerate the research and development and production of innovative vaccines, provide solid guarantees for safeguarding public health, and contribute to the innovative development of China's biopharmaceutical industry.